etravirine
NDC 60219-1721, etravirine, tablet, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 60219-1721
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214196
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1721 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ETRAVIRINE100 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 60219-1721-7 | 60219172107 | 120 TABLET in 1 BOTTLE, PLASTIC (60219-1721-7) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4e009f19-4609-4020-bee1-dc27c504046cNADAC price for package 60219172107
GET /v1/drugs/nadac/60219172107
Use it
Look up 60219-1721 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1721 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 60219-1721. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.